Literature DB >> 8581139

Highly sensitive and specific high-performance liquid chromatographic analysis of 7-hydroxywarfarin, a marker for human cytochrome P-4502C9 activity.

D Lang1, R Böcker.   

Abstract

The formation of 7-hydroxywarfarin in incubations of (S)-warfarin with human liver microsomes reflects their cytochrome P-4502C9 activity. This paper describes a rapid high-performance liquid chromatographic method for the determination of 7-hydroxywarfarin with high sensitivity, selectivity, and a simple sample clean-up procedure. Separation was achieved with a C18 reversed-phase column and quantification by fluorometric detection. The method employs an internal standard resulting in good accuracy and precision. The limit of detection is 150 fmol for 7-hydroxywarfarin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581139     DOI: 10.1016/0378-4347(95)00222-5

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  5 in total

1.  Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.

Authors:  K Ohyama; M Nakajima; M Suzuki; N Shimada; H Yamazaki; T Yokoi
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

2.  Electrocatalytic drug metabolism by CYP2C9 bonded to a self-assembled monolayer-modified electrode.

Authors:  Mingli Yang; Jarod L Kabulski; Lance Wollenberg; Xinqi Chen; Murali Subramanian; Timothy S Tracy; David Lederman; Peter M Gannett; Nianqiang Wu
Journal:  Drug Metab Dispos       Date:  2009-01-26       Impact factor: 3.922

3.  CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.

Authors:  Charles W Locuson; Larry C Wienkers; Jeffrey P Jones; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2007-04-19       Impact factor: 3.922

4.  Functioning of drug-metabolizing microsomal cytochrome P450s: In silico probing of proteins suggests that the distal heme 'active site' pocket plays a relatively 'passive role' in some enzyme-substrate interactions.

Authors:  Avanthika Venkatachalam; Abhinav Parashar; Kelath Murali Manoj
Journal:  In Silico Pharmacol       Date:  2016-02-19

5.  Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 Cells.

Authors:  Huihui Du; Zhiyun Wei; Yucai Yan; Yuyu Xiong; Xiaoqing Zhang; Lu Shen; Yunfeng Ruan; Xi Wu; Qingqing Xu; Lin He; Shengying Qin
Journal:  Front Pharmacol       Date:  2016-04-25       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.